Given that RA pathogenesis is characterized by heightened TNF-α signaling, this observation could potentially elucidate the clinical phenomenon of non-responsiveness to TNF-α inhibitor therapy observed in subsets of RA patients [115,116]. The gene discussed is TNF; the disease is rheumatoid arthritis.